Astrana Health (ASTH) Falls After Earnings As The Bull Case Still Points To Value

Detailed summary

Astrana Health (ASTH) just posted third quarter earnings that showed net income of US$12.95 million and earnings per share of US$0.26, with nine month profits reaching US$47.13…

Astrana Health (ASTH) just posted third quarter earnings that showed net income of US$12.95 million and earnings per share of US$0.26, with nine month profits reaching US$47.13 million.

The market reaction has been sharp in the short term, with the share price down 11.6% over the past day and 7.1% over the past month, even though Astrana Health's year to date share price return is up 36.8% and the 1 year total shareholder return sits at 35.1%. This suggests that recent selling contrasts with a still positive longer run record.

Scan how Astrana Health compares with other profit focused healthcare stocks by reviewing our curated list of 35 healthcare AI stocks.

Astrana Health is now trading well below recent highs even after reporting higher earnings, which raises a simple issue for investors. Has most of the easy upside already played out, or is the recent pullback still offering value?

Opening of the article, excerpted from Yahoo Finance. To read the rest, open the article on the publisher's site.